Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Bupivacaine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/20/2018
»Therapeutic Categories: Anesthesia
Eugia US LLC (Revised 08/05/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Available | Check wholesalers for inventory | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Available | Check wholesalers for inventory | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-169-10) | Available | Check wholesalers for inventory | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-170-30) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Unavailable | On backorder. Recovery: TBD. Check wholesalers for inventory | Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Available | Check wholesalers for inventory | |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Available | Check wholesalers for inventory |
Fresenius Kabi USA, LLC (Reverified 09/04/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Unavailable | Not available at this time. | Demand increase for the drug |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Unavailable | Not available at this time. | Delay in shipping of the drug |
| Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Available | Check wholesalers for inventory | |
| Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Available | Check wholesalers for inventory |
Hospira, Inc., a Pfizer Company (Revised 08/26/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01) | Available | ||
| Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02) | Available | ||
| Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01) | Available | ||
| Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01) | Available | ||
| Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02) | Available | ||
| Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01) | Available | ||
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Available | ||
| Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02) | Available | ||
| Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01) | Available | ||
| Marcaine, Injection, Marcaine 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1559-10) | Available | ||
| Marcaine, Injection, Marcaine 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1559-30) | Available | ||
| Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1587-50) | Available | ||
| Marcaine, Injection, Marcaine 50 mg/10 mL (5 mg/mL) (NDC 0409-1560-10) | Available | ||
| Marcaine, Injection, Marcaine 150 mg/30 mL (5 mg/mL) (NDC 0409-1560-29) | Available | ||
| Marcaine, Injection, Marcaine 250 mg/50 mL (5 mg/mL) (NDC 0409-1610-50) | Limited Availability | Limited Supply Available. Next Delivery and Estimated Recovery: December 2027 | Delay in shipping of the drug |
| Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1582-10) | Available | ||
| Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1582-29) | Available | ||
| Injection, 0.25%; 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-10) | Available | ||
| Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10) | Available | ||
| Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62) | Available |
Huons Co., Ltd (Reverified 08/05/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | Available |
Kindos Pharmaceuticals Co. Ltd. (Reverified 07/11/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Available | Meitheal Pharmaceuticals is distributor/labeler; product is available | |
| Injection, 5 mg/1 mL (NDC 71288-726-52) | Available | Meitheal Pharmaceuticals is distributor/labeler; product is available | |
| Injection, 2.5 mg/1 mL (NDC 71288-722-32) | Available | Meitheal Pharmaceuticals is distributor/labeler; product is available | |
| Injection, 5 mg/1 mL (NDC 71288-725-32) | Available | Meitheal Pharmaceuticals is distributor/labeler; product is available | |
| Injection, 7.5 mg/1 mL (NDC 71288-728-32) | Available | Meitheal Pharmaceuticals is distributor/labeler; product is available |
Somerset Therapeutics, LLC (Reverified 08/30/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Injection, 2.5 mg/1 mL (NDC 70069-752-25) | Available | ||
| Injection, 5 mg/1 mL (NDC 70069-753-25) | Available |